Company Overview - Origin Agritech Ltd. is a leading Chinese agricultural technology company founded in 1997 and headquartered in Beijing [5] - The company specializes in crop seed biotechnologies, with notable products including phytase corn, which was the first transgenic corn to receive a Bio-Safety Certificate from China's Ministry of Agriculture [5] - Origin has developed a robust biotechnology seed pipeline featuring products with glyphosate tolerance and pest resistance traits [5] Upcoming Financial Results - The company will announce its financial results for fiscal year 2024 on February 10th after market close [1] - A conference call will be held on February 11th at 8 a.m. ET to discuss the financial results and provide a business update [1][2] Conference Call Details - The conference call will be led by CEO Mr. Weibin Yan and CFO Mr. Patrick Cheng, who will be available for questions [2] - Investors can submit written questions by February 6th via email [3] - Access to the call can be made by phone or through a webcast, with specific dial-in numbers and a conference ID provided [3]

Core Insights - Origin Agritech Ltd. has signed cooperation agreements with 12 prominent agricultural companies to enhance agricultural biotechnology in China [1][4] - The agreements were announced during a seminar showcasing Origin's innovative "smart plant type" corn varieties and the MIGC 20K technology [2][3] Group 1: Agreements and Collaborations - The agreements focus on comprehensive biotechnology services aimed at advancing agricultural practices [2] - The event featured leading agricultural experts, highlighting the significance of collaboration in the seed industry [2] Group 2: Technological Innovations - Origin introduced the MIGC 20K, a multi-function integrated gene chip that utilizes data from 40 million SNP sites and 10 million detection data sites for efficient molecular breeding [3] - The MIGC 20K technology is expected to enhance transgenic component identification and variety rights protection [3] Group 3: Strategic Goals - The CEO of Origin Agritech emphasized that these agreements will strengthen the company's position in the seed industry and foster innovation for farmers [4] - The Vice President noted that the collaboration will accelerate the development and commercialization of innovative seed varieties, contributing to the modernization of China's agricultural sector [4] Group 4: Company Background - Origin Agritech, founded in 1997, is a leading agricultural technology company in China, known for its pioneering work in crop seed biotechnologies [5] - The company has developed a robust biotechnology seed pipeline, including transgenic corn with glyphosate tolerance and pest resistance traits [5]

Core Viewpoint - Origin Agritech Ltd. has made significant advancements in its biotechnology breeding program and announced a groundbreaking partnership aimed at enhancing corn development and smart plant technology [1][2][3]. Group 1: Company Developments - Origin Agritech's CEO, Yan Weibin, emphasized the company's strategic vision to become a high-tech seed service company led by biotechnology [2]. - The company has established a three-way partnership with China Agricultural University and the Beijing Academy of Agricultural and Forestry Sciences to focus on corn "smart plant type" improvement and innovative variety development [2][3]. - Origin Agritech is committed to substantial R&D investments and aims to provide leading biotechnology services while integrating digital and information technologies [4]. Group 2: Achievements and Capabilities - The company has developed a large-scale corn genetic platform for efficient functional gene exploration and created the world's first corn haploid induction line Hi3 gene editing technology system [6]. - Origin Agritech has accumulated nearly 300,000 corn germplasm resources and has received authorization for multiple gene editing traits, including leaf angle, plant height, and rust resistance [6]. - The company obtained the second-generation BT and GT GMO corn BBL2-2 biosafety certificate in May 2024 and established the "Origin Marker Biological Breeding Service Consortium" to launch comprehensive biotechnology services [6].

Corporate Strategy - The conference focused on Origin Agritech's corporate strategy for 2025 and the overall development of China's seed industry [1] - Origin Agritech announced its 2025 corporate development strategy, including its vision, values, market positioning, and slogan [4] Chairman and CEO Insights - Dr. Gengchan Han, Chairman of Origin Agritech, outlined the Company's vision to establish three platforms: a technology development and cooperation platform, a profit-sharing platform, and an innovation platform [2] - Mr. Weibin Yan, CEO of Origin Agritech, emphasized the significant opportunities in China's seed industry and the Company's ambition to become a leading player in Asia, including key projects in research and development [3][6] Industry Trends and Goals - Experts provided insights into China's corn industry's current state and future trends, highlighting the importance of "easy seed production" and the potential of bio-breeding [4] - The Company aims to strengthen its seed business, expand its biotechnology platform capabilities, and explore new nutritional food businesses [4] Future Commitments - Origin Agritech is committed to becoming a trusted leader in China's seed industry and plans to accelerate the internationalization of biotechnology [5] - The Company aims to vertically integrate its seed business to achieve its ambitious goals [5]

Core Insights - Origin Agritech Ltd. has established the "Origin Marker Biological Breeding Service Consortium" in partnership with China Golden Marker Biotechnology Co., Ltd. to license its GMO insect-resistant and herbicide-tolerant traits and accelerate gene editing technology application in breeding programs [1][2] Group 1: Consortium Formation and Objectives - The consortium aims to promote the commercialization of Origin's GMO and gene editing technologies, following the receipt of a GMO safety certificate for its transgenic maize, BBL2-2, in May 2024 [1][2] - The partnership with China Golden Marker, which has invested 67 million yuan in a molecular marker laboratory, will enhance the consortium's capabilities in processing over 1 million samples and generating over 1 billion SNP data points annually [3] Group 2: Key Projects and Innovations - The consortium is advancing three key projects: commercialization of the BBL2-2 GMO maize event, promotion of the maize-induced gene editing system, and innovation in maize germplasm resources [3] - The gene editing technology can reduce the traditional breeding timeline from 3-4 years to just one year, improving traits such as drought resistance and disease resilience in maize [2] Group 3: Industry Impact and Relationships - The consortium has established cooperative relationships with dozens of breeding companies across China, improving over 100 corn varieties planted in key corn-producing regions [4] - The initiative is expected to significantly accelerate the commercialization of GMO and gene editing technologies, streamlining the path from lab to market [4]

Core Viewpoint - Origin Agritech Ltd. has appointed Mr. Weibin Yan as the new CEO, succeeding Dr. Gengchen Han, who will remain as Chairman of the Board. This leadership change is aimed at driving the company's growth and innovation in agricultural technology [1][3]. Company Overview - Origin Agritech Limited, founded in 1997, is a leading Chinese agricultural technology company headquartered in Zhong-Guan-Cun Life Science Park, Beijing. The company specializes in crop seed biotechnologies and has developed a robust biotechnology seed pipeline [4]. Leadership Background - Mr. Weibin Yan has extensive experience in the agricultural sector, previously serving as Vice-Chairman of the Hunan Provincial Federation of Industry and Commerce and as Chairman of Ausnutria Dairy Corporation Ltd. until September 2023. He has also held various executive roles at Yuan Longping High-tech Agriculture Co., Ltd. [2][3]. - Mr. Yan has a history with Origin Agritech, having served as an independent director from 2017 to 2018, which provides him with a deep understanding of the company's operations and strategic direction [2]. Strategic Goals - The new CEO, Mr. Yan, expressed enthusiasm about leading Origin Agritech during a pivotal time, focusing on commercializing advancements in GMO technology and gene editing to enhance global agriculture [3]. - Dr. Gengchen Han emphasized Mr. Yan's proven leadership and experience in agriculture as key factors for guiding the company towards its growth and innovation objectives [3].

BEIJING, Aug. 8, 2024 /PRNewswire/ -- Origin Agritech Ltd. (NASDAQ: SEED) (the "Company" or "Origin"), a leading Chinese agricultural technology company, is pleased to announce the appointment of Cheng Chi Kin (Patrick Cheng) as Chief Financial Officer and to the Board of Directors of the Company, effective immediately. With a distinguished career spanning over three decades in corporate management, investment, and financial control, Patrick Cheng will drive Origin Agritech's financial strategy and operatio ...

Core Viewpoint - Origin Agritech Ltd. has appointed Mr. Li Yang as Chief Operating Officer and a member of the Board of Directors, effective immediately, to enhance its operational strategy and execution [1][3]. Company Overview - Origin Agritech Limited, founded in 1997 and headquartered in Beijing, is a leading Chinese agricultural technology company known for its innovations in crop seed biotechnologies [4]. - The company has developed a robust biotechnology seed pipeline, including phytase corn, which was the first transgenic corn to receive a Bio-Safety Certificate from China's Ministry of Agriculture [4]. Leadership Appointment - Mr. Li Yang brings over 20 years of experience in investment activities and corporate management, having held directorships in several prominent companies listed on Hong Kong stock exchanges [2]. - His expertise includes corporate governance, strategic planning, mergers and acquisitions, and operational management, which will be crucial for Origin Agritech's market presence and technological expansion [2]. Executive Statements - Dr. Gengchen Han, Chairman and CEO of Origin Agritech, expressed confidence in Mr. Li Yang's leadership and operational expertise, anticipating significant contributions to the company's growth and success [3]. - Mr. Li Yang expressed enthusiasm about joining Origin Agritech and aims to enhance operational efficiency and strategic development [3]. Educational Background - Mr. Li Yang holds a Master's Degree in World Economics from the Chinese Academy of Social Sciences and an MBA from Shenzhen Economic and Management Institute, along with a diploma from Shenzhen University [3].

Core Insights - SEED Therapeutics has entered a strategic research collaboration with Eisai to develop novel molecular glue degraders targeting neurodegeneration and oncology [1][2] - The collaboration includes financial terms that allow SEED to receive up to $1.5 billion in payments and tiered royalties from Eisai [2] - SEED has initiated Series A-3 financing, raising $24 million in the first close, with a second close planned for Q4 2024 [3] Collaboration Details - SEED will lead preclinical discovery activities, while Eisai will have exclusive rights to develop and commercialize the resulting compounds [2] - This collaboration follows an ongoing partnership between SEED and Eli Lilly for the development of molecular glue degraders [2] Series A-3 Financing - The Series A-3 financing aims to accelerate SEED's clinical development in cancer and neurodegeneration, expanding its TPD platform and pipeline [3] - SEED plans to advance its oral RBM39 Degrader into Phase 1 testing in 2025 and its Tau degrader program for Alzheimer's into in vivo efficacy testing in 2025, with an IND submission in 2026 [3] Company Background - SEED Therapeutics focuses on developing molecular glues and targeted protein degradation therapies for previously undruggable targets, with a growing pipeline in neurodegeneration and oncology [6] - The company has collaborations with both Eisai and Eli Lilly, enhancing its capabilities in drug development for neurodegenerative diseases [5][6] Eisai's Role - Eisai is recognized for its commitment to human health care and aims to address unmet medical needs in neurology and oncology through innovative products [7] - The collaboration with SEED is seen as a unique opportunity to leverage molecular glue technology in both oncology and neurology [4]

Core Viewpoint - Origin Agritech Ltd. projects significant revenue growth through 2029, driven by its GMO corn products and expanding market share in China's agricultural sector [1][2]. Revenue Projections - In 2022, total revenue was ￥52,580 million ($7,240 million), which increased to ￥93,307 million ($12,848 million) in 2023 [2]. - Expected total revenue for 2024 is ￥105,000 million ($14,458 million), with contributions from hybrid seeds and the introduction of GMO corn expected to begin in 2025 [2]. - By 2029, total revenue is projected to reach ￥958,747 million ($132,019 million), with GMO corn sales and intellectual property (IP) granting significantly contributing to revenue streams [2]. Market Share and Growth - The company aims to capture a 5% market share of the GMO corn market, which is projected to cover about 20 million mu of the total corn planting area in China [2]. - By 2029, it is anticipated that GMO corn will account for 70% of the total corn planting area in China, approximately 400 million mu [2]. Technological Advancements - Origin Agritech has a strong biotechnology seed pipeline, including products with glyphosate tolerance and pest resistance traits [3]. - The company was the first to receive a Bio-Safety Certificate for its phytase corn from China's Ministry of Agriculture, highlighting its leadership in agricultural biotechnology [3]. Leadership Commentary - Dr. Gengchen Han, Chairman and CEO, expressed optimism about the company's growth prospects and commitment to addressing global food security challenges through innovation and sustainable agricultural practices [1][2].